Four Sectors Driving Jean-Pierre Conte’s 2026 Deal Pipeline

Lupine Crest Capital spreads its activity across private equity, real estate, and venture, yet the operating focus that defines its deal flow narrows to four arenas: healthcare, financial services, software, and industrial technology.

Jean-Pierre Conte, managing partner of the firm, built a career across that exact mix, and the 2026 data explains why each of the four suits a patient-capital buyer right now.

Long-Cycle Sectors: Healthcare and Financial Services

Healthcare rewards hold periods that fund vintages rarely allow. Service platforms commonly take five to seven years to build, longer when clinical integration enters the picture, and demographic demand keeps driving consolidation.

Financial services fits the family office model just as cleanly. Insurance brokerages and payment infrastructure throw off recurring revenue, and assets priced on continued exit windows often rotate to longer-hold buyers at lower entry multiples when those windows close early. Both businesses also carry the kind of steady cash flow a balance-sheet owner can underwrite with confidence, which keeps the sector near the top of the firm’s list.

AI-Shaped Sectors: Software and Industrial Technology

Software is where 2026 economics shift most visibly. Corporate buyers pay up for recurring-revenue, data-rich businesses. That leaves targets in the $50 million to $500 million revenue band for buyers built to underwrite them.

Industrial technology is heading into its busiest stretch in memory, with automation, electrification, and advanced manufacturing pulling capital in. PwC’s industrial outlook found deals above $5 billion made up 52% of sector value in 2025, up from 18% the prior fiscal year.

Why Four, Not Forty

Concentration over broad allocation hands a direct investor pattern recognition that a generalist cannot match. Experience underwriting healthcare across cycles surfaces the operational warning signs a newcomer would miss, and the same depth repeats in the other three.

That selectivity matches where the market now rewards conviction. Each of Conte’s four arenas has produced returns for patient capital across multiple cycles, and the 2026 read gives little reason to expect the pattern to break. Deal flow that does not lean on any single market regime is the practical payoff, since weakness in one sector rarely arrives at the same moment as weakness in the others.